Townsquare Capital LLC Vbi Vaccines Inc Transaction History

Townsquare Capital LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$2.61 - $4.17 $41,760 - $66,720	-16,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.91 - $4.32 $17,460 - $25,920	6,000 Added 60.0%	16,000 $50,000
Q2 2020 Aug 17, 2020	BUY	$0.87 - $3.13 $8,700 - $31,300	10,000 New	10,000 $38,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Townsquare Capital LLC with notifications on news.